253 related articles for article (PubMed ID: 26639459)
21. Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson's disease patients with penicillamine-induced allergy or early neurological deterioration.
Zhu XQ; Li LY; Yang WM; Wang Y
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32809015
[TBL] [Abstract][Full Text] [Related]
22. [Wilsons disease].
Mareček Z; Brůha R
Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
[TBL] [Abstract][Full Text] [Related]
23. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
24. [Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy].
Serra B; Primo J; García M; Amorós I; Aragó M; Merino C
Gastroenterol Hepatol; 2004 May; 27(5):307-10. PubMed ID: 15117609
[TBL] [Abstract][Full Text] [Related]
25. Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease.
Jacquelet E; Poujois A; Pheulpin MC; Demain A; Tinant N; Gastellier N; Woimant F
J Inherit Metab Dis; 2021 Nov; 44(6):1481-1488. PubMed ID: 34480375
[TBL] [Abstract][Full Text] [Related]
26. Wilson's disease--treatment of psychiatric manifestations in pregnancy.
Rich AM; Lajoie TM
Psychosomatics; 2012; 53(2):175-7. PubMed ID: 22424165
[No Abstract] [Full Text] [Related]
27. Trientine-induced neurological deterioration in a patient with Wilson's disease.
Kim B; Chung SJ; Shin HW
J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
[TBL] [Abstract][Full Text] [Related]
28. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Merle U; Schaefer M; Ferenci P; Stremmel W
Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Wilson's disease: penicillamine or triene?
Kiechl SG; Willeit J; Aichner F; Felber S
Acta Neurol Scand; 1992 Feb; 85(2):154-7. PubMed ID: 1574992
[No Abstract] [Full Text] [Related]
30. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
Brewer GJ
J Cell Mol Med; 2003; 7(1):11-20. PubMed ID: 12767257
[TBL] [Abstract][Full Text] [Related]
31. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
[TBL] [Abstract][Full Text] [Related]
32. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
[TBL] [Abstract][Full Text] [Related]
33. Wilson's Disease: A Review for the General Pediatrician.
Capone K; Azzam RK
Pediatr Ann; 2018 Nov; 47(11):e440-e444. PubMed ID: 30423186
[TBL] [Abstract][Full Text] [Related]
34. A copper for your thoughts.
Coates RA
J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
[No Abstract] [Full Text] [Related]
35. Treatment and management of Wilson's disease.
Shimizu N; Yamaguchi Y; Aoki T
Pediatr Int; 1999 Aug; 41(4):419-22. PubMed ID: 10453198
[TBL] [Abstract][Full Text] [Related]
36. Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.
Deguchi K; Sasaki I; Touge T; Tsukaguchi M; Ikeda K; Shimamura M; Urai Y; Watanabe S; Takeuchi H; Kuriyama S
J Neurol; 2005 Apr; 252(4):495-7. PubMed ID: 15726258
[No Abstract] [Full Text] [Related]
37. [Wilson's disease: physiopathological, clinical and therapeutic considerations].
Pérez-Aguilar F
Gastroenterol Hepatol; 2003 Jan; 26(1):42-51. PubMed ID: 12525328
[No Abstract] [Full Text] [Related]
38. Wilson's disease: overview.
Lucena-Valera A; Ruz-Zafra P; Ampuero J
Med Clin (Barc); 2023 Mar; 160(6):261-267. PubMed ID: 36697289
[TBL] [Abstract][Full Text] [Related]
39. [A study of trientine therapy in Wilson's disease with neurological symptoms].
Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
[TBL] [Abstract][Full Text] [Related]
40. Initial therapy of patients with Wilson's disease with tetrathiomolybdate.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkin V; Tankanow R; Young AB; Kluin KJ
Arch Neurol; 1991 Jan; 48(1):42-7. PubMed ID: 1986725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
